Literature DB >> 6338925

Identification of the D-glucose-inhibitable cytochalasin B binding site as the glucose transporter in rat diaphragm plasma and microsomal membranes.

L J Wardzala, B Jeanrenaud.   

Abstract

[3H]Cytochalasin B binding and its competitive inhibition by D-glucose have been used to identify, the glucose transporter in plasma and microsomal membranes prepared from intact rat diaphragm. Scatchard plot analysis of [3H]cytochalasin B binding yields a binding site with a dissociation constant of roughly 110 nM. Since the inhibition constant of cytochalasin B for D-glucose uptake by diaphragm plasma membranes is similar to this value, this site is identified as the glucose transporter. Plasma membranes prepared from diaphragms bind approx. 17 pmol of cytochalasin B/mg of membrane protein to the D-glucose-inhibitable site. If 280 nM (40000 microunits/ml) insulin is present during incubation, cytochalasin B binding is increased roughly 2-fold without alteration in the dissociation constant of this site. In addition, membranes in the microsomal fraction contain 21 pmol of D-glucose-inhibitable cytochalasin B binding sites/mg of membrane protein. In the presence of insulin during incubation the number of these sites in the microsomal fraction is decreased to 9 pmol/mg of membrane protein. These results suggest that rat diaphragm contain glucose transporters with characteristics identical to those observed for the rat adipose cell glucose transporter. In addition, insulin stimulates glucose transport in rat diaphragm through a translocation of functionally identical glucose transporters from an intracellular membrane pool to the plasma membrane without an alteration in the characteristics of these sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338925     DOI: 10.1016/0005-2736(83)90315-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  GLUT4 exocytosis.

Authors:  Jacqueline Stöckli; Daniel J Fazakerley; David E James
Journal:  J Cell Sci       Date:  2011-12-15       Impact factor: 5.285

Review 2.  An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  Mechanism of the decrease in hexose transport by mouse mammary epithelial cells caused by fasting.

Authors:  C G Prosser
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

Review 4.  The glucose transporter family: structure, function and tissue-specific expression.

Authors:  G W Gould; G D Holman
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

5.  Insulin stimulation of glucose transport activity in rat skeletal muscle: increase in cell surface GLUT4 as assessed by photolabelling.

Authors:  C M Wilson; S W Cushman
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Insulin modifies the properties of glucose transporters in rat brown adipose tissue.

Authors:  R Greco-Perotto; F Assimacopoulos-Jeannet; B Jeanrenaud
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

7.  Glucose transport system in UMR-106-01 osteoblastic osteosarcoma cells: regulation by insulin.

Authors:  E A Ituarte; L R Halstead; A Iida-Klein; H G Ituarte; T J Hahn
Journal:  Calcif Tissue Int       Date:  1989-07       Impact factor: 4.333

8.  Distribution of glucose transporters in membrane fractions isolated from human adipose cells. Relation to cell size.

Authors:  E Karnieli; A Barzilai; R Rafaeloff; M Armoni
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Glucose regulates its transport in L8 myocytes by modulating cellular trafficking of the transporter GLUT-1.

Authors:  R Greco-Perotto; E Wertheimer; B Jeanrenaud; E Cerasi; S Sasson
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

10.  Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.

Authors:  P A King; E D Horton; M F Hirshman; E S Horton
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.